Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Comparative, Randomized, Placebo-controlled Study on Immunogenicity, Reactogenicity and Safety of Live Cell-based Vaccine Against Smallpox and Other Orthopoxvirus Infections (VACΔ6 Vaccine) in Volunteers Aged 18-60 Years

NCT05846243 is registered in ClinicalTrials.gov with Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" as lead sponsor.

NCT NCT05846243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05846243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Comparative, Randomized, Placebo-controlled Study on Immunogenicity, Reactogenicity and Safety of Live Cell-based Vaccine Against Smallpox and Other Orthopoxvirus Infections (VACΔ6 Vaccine) in Volunteers Aged 18-60 Years
Lead sponsor
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
Phase
Phase 2/3
Overall status
Completed
Start date
October 1, 2021
Completion date
April 1, 2022
Enrollment
334 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cowpox, monkeypox, smallpox, vaccinia virus infection